![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach: Dokumententyp |
Veröffentlichungsdatum
Anzahl der Publikationen: 2
2021
Chi, Kim N.; Chowdhury, Simon; Bjartell, Anders; Byung Ha, Chung; Gomes, Andrea J. Pereira de Santana; Given, Robert; Juarez, Alvaro; Merseburger, Axel S.; Ozguroglu, Mustafa; Uemura, Hirotsugu; Ye, Dingwei; Brookman-May, Sabine; Mundle, Suneel D.; McCarthy, Sharon A.; Larsen, Julie S.; Sun, Weili; Bevans, Katherine B.; Zhang, Ke; Bandyopadhyay, Nibedita und Agarwal, Neeraj
(2021):
Apalutamide in Patients With Metastatic Castration-Sensitive Prostate Cancer: Final Survival Analysis of the Randomized, Double-Blind, Phase III TITAN Study.
In: Journal of Clinical Oncology, Bd. 39, Nr. 20: S. 2294-2304
2016
Dreyling, Martin; Jurczak, Wojciech; Jerkeman, Mats; Santucci Silva, Rodrigo; Rusconi, Chiara; Trneny, Marek; Offner, Fritz; Caballero, Dolores; Joao, Cristina; Witzens-Harig, Mathias; Hess, Georg; Bence-Bruckler, Isabelle; Cho, Seok-Goo; Bothos, John; Goldberg, Jenna D.; Enny, Christopher; Traina, Shana; Balasubramanian, Sriram; Bandyopadhyay, Nibedita; Sun, Steven; Vermeulen, Jessica; Rizo, Aleksandra und Rule, Simon
(2016):
Ibrutinib versus temsirolimus in patients with relapsed or refractory mantle-cell lymphoma: an international, randomised, open-label, phase study.
In: Lancet, Bd. 387, Nr. 10020: S. 770-778